Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

HitGen patents HDAC inhibitors

Nov. 13, 2020

First patient treated in phase I study of MaaT-033

Nov. 13, 2020

Curasight initiates preclinical study of uTREAT therapy in brain cancer

Nov. 13, 2020

Enrollment completed and interim data presented from DRIIV-1b study of AsiDNA

Nov. 13, 2020

China IND approval for Apollomics' multikinase inhibitor APL-102

Nov. 12, 2020

Metabolic pathway-based TNBC subtyping reveals potential new targets

Nov. 12, 2020

Massachusetts Institute of Technology synthesizes compounds for cancer

Nov. 12, 2020

Kuling Therapeutics patents RORC antagonists

Nov. 12, 2020

Early clinical data reported for [177Lu]rhPSMA-7.3 in mCRPC

Nov. 12, 2020

NiKang Therapeutics synthesizes new HIF-2alpha inhibitors

Nov. 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...